If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure ...

United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report ...

The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD). Shareholders ...

United Therapeutics Corp United Therapeutics Corp UTHR Stock XNAS Rating as of Jul 4, 2025 Download PDF More Actions ...

United Therapeutics Corporation (UTHR) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions ...

EU chief, Trump had 'good exchange' by phone Sunday CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S.

Exclusive agreement includes over $70 million in upfront and milestone payments to LENZ in addition to double-digit royalties ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the. On June 4, the company published pre-specified analyses for its ...

CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food Drug Administration (FDA) has approved the comp ...

U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, this patent would provide protection to ...